Grifols (GIKLY) Enterprise Value Growth (1y) (2011 - 2025)

Grifols (GIKLY) Enterprise Value Growth (1y) (2011 - 2025) Analysis & Trends

Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn
10 Grifols - - -

Historic Data

Download Data
DateValue
Dec 31, 2025 8.41%
Dec 31, 2024 -77.20%
Dec 31, 2023 1.66%
Dec 31, 2022 80.09%
Dec 31, 2021 -346.88%
Dec 31, 2020 10.14%
Sep 30, 2020 373.17%
Mar 31, 2020 475.36%
Dec 31, 2019 267.98%
Sep 30, 2019 58.33%
Mar 31, 2019 -38.36%
Dec 31, 2018 36.70%
Jun 30, 2018 5.15%
Mar 31, 2018 451.17%
Dec 31, 2017 -9.21%
Jun 30, 2017 10.60%
Mar 31, 2017 85.90%
Dec 31, 2016 22.91%
Sep 30, 2016 0.17%
Jun 30, 2016 -3.83%